BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32493826)

  • 21. Antibody responses and protection against influenza virus infection in different congenic strains of mice immunized intranasally with adjuvant-combined A/Beijing/262/95 (H1N1) virus hemagglutinin or neuraminidase.
    Yoshikawa T; Suzuki Y; Nomoto A; Sata T; Kurata T; Tamura Si
    Vaccine; 2002 Nov; 21(1-2):60-6. PubMed ID: 12443663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.
    Tian X; Landreth S; Lu Y; Pandey K; Zhou Y
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33177192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infection of influenza virus neuraminidase-vaccinated mice with homologous influenza virus leads to strong protection against heterologous influenza viruses.
    He B; Chang H; Liu Z; Huang C; Liu X; Zheng D; Fang F; Sun B; Chen Z
    J Gen Virol; 2014 Dec; 95(Pt 12):2627-2637. PubMed ID: 25170051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs.
    Chen Z; Matsuo K; Asanuma H; Takahashi H; Iwasaki T; Suzuki Y; Aizawa C; Kurata T; Tamura S
    Vaccine; 1999 Feb; 17(7-8):653-9. PubMed ID: 10067670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza.
    Job ER; Schotsaert M; IbaƱez LI; Smet A; Ysenbaert T; Roose K; Dai M; de Haan CAM; Kleanthous H; Vogel TU; Saelens X
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29167342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune effects against influenza A virus and a novel DNA vaccine with co-expression of haemagglutinin- and neuraminidase-encoding genes.
    Zhang W; Li W; Li Y; Li H; Wang B; Wang F; Zhu Y; Jiang Z; Zhong L; Li M
    J Med Microbiol; 2009 Jul; 58(Pt 7):845-854. PubMed ID: 19498203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incorporation of conserved nucleoprotein into influenza virus-like particles could provoke a broad protective immune response in BALB/c mice and chickens.
    Xue C; Tian G; Chen X; Liu Q; Ma J; Xu S; Li X; Chen H; Cao Y
    Virus Res; 2015 Jan; 195():35-42. PubMed ID: 25312452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imprinted Anti-Hemagglutinin and Anti-Neuraminidase Antibody Responses after Childhood Infections of A(H1N1) and A(H1N1)pdm09 Influenza Viruses.
    Daulagala P; Mann BR; Leung K; Lau EHY; Yung L; Lei R; Nizami SIN; Wu JT; Chiu SS; Daniels RS; Wu NC; Wentworth D; Peiris M; Yen HL
    mBio; 2023 Jun; 14(3):e0008423. PubMed ID: 37070986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Broadly Reactive H2 Hemagglutinin Vaccines Elicit Cross-Reactive Antibodies in Ferrets Preimmune to Seasonal Influenza A Viruses.
    Reneer ZB; Skarlupka AL; Jamieson PJ; Ross TM
    mSphere; 2021 Mar; 6(2):. PubMed ID: 33692193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of Immune Response towards Generation of Universal Anti-HA-Stalk Antibodies after Immunization of Broiler Hens with Triple H5N1/NA-HA-M1 VLPs.
    Gromadzka B; Chraniuk M; Hovhannisyan L; Uranowska K; Szewczyk B; Narajczyk M; Panasiuk M
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine.
    Johansson BE
    Vaccine; 1999 Apr; 17(15-16):2073-80. PubMed ID: 10217609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Balancing the influenza neuraminidase and hemagglutinin responses by exchanging the vaccine virus backbone.
    Gao J; Wan H; Li X; Rakic Martinez M; Klenow L; Gao Y; Ye Z; Daniels R
    PLoS Pathog; 2021 Apr; 17(4):e1009171. PubMed ID: 33872324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity and Protection Against Influenza H7N3 in Mice by Modified Vaccinia Virus Ankara Vectors Expressing Influenza Virus Hemagglutinin or Neuraminidase.
    Meseda CA; Atukorale V; Soto J; Eichelberger MC; Gao J; Wang W; Weiss CD; Weir JP
    Sci Rep; 2018 Mar; 8(1):5364. PubMed ID: 29599502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus.
    Lu X; Liu F; Zeng H; Sheu T; Achenbach JE; Veguilla V; Gubareva LV; Garten R; Smith C; Yang H; Stevens J; Xu X; Katz JM; Tumpey TM
    Virology; 2014 Apr; 454-455():169-75. PubMed ID: 24725943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design of the Recombinant Influenza Neuraminidase Antigen Is Crucial for Its Biochemical Properties and Protective Efficacy.
    Gao J; Klenow L; Parsons L; Malik T; Phue JN; Gao Z; Withers SG; Cipollo J; Daniels R; Wan H
    J Virol; 2021 Nov; 95(24):e0116021. PubMed ID: 34613807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuraminidase (NA) 370-Loop Mutations of the 2009 Pandemic H1N1 Viruses Affect NA Enzyme Activity, Hemagglutination Titer, Mouse Virulence, and Inactivated-Virus Immunogenicity.
    Chen TH; Chen CC; Wu SC
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Recombinant Influenza Virus Neuraminidase Vaccine Candidate Stabilized by a Measles Virus Phosphoprotein Tetramerization Domain Provides Robust Protection from Virus Challenge in the Mouse Model.
    Strohmeier S; Amanat F; Zhu X; McMahon M; Deming ME; Pasetti MF; Neuzil KM; Wilson IA; Krammer F
    mBio; 2021 Dec; 12(6):e0224121. PubMed ID: 34809451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.
    Smith GE; Flyer DC; Raghunandan R; Liu Y; Wei Z; Wu Y; Kpamegan E; Courbron D; Fries LF; Glenn GM
    Vaccine; 2013 Sep; 31(40):4305-13. PubMed ID: 23891795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-protection against influenza viruses by chimeric M2e-H3 stalk protein or multi-subtype neuraminidase plus M2e virus-like particle vaccine in ferrets.
    Kim KH; Bhatnagar N; Subbiah J; Liu R; Pal SS; Raha JR; Grovenstein P; Shin CH; Wang BZ; Kang SM
    Virology; 2024 Jul; 595():110097. PubMed ID: 38685171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017.
    Catani JPP; Smet A; Ysenbaert T; Vuylsteke M; Bottu G; Mathys J; Botzki A; Cortes-Garcia G; Strugnell T; Gomila R; Hamberger J; Catalan J; Ustyugova IV; Farrell T; Stegalkina S; Ray S; LaRue L; Saelens X; Vogel TU
    Elife; 2024 May; 12():. PubMed ID: 38805550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.